Please use this identifier to cite or link to this item:
https://hdl.handle.net/1/3174| Title: | FRONTLINE ASCIMINIB FOR CHRONIC PHASE CML: LONG TERM SAFETY AND EFFICACY IN THE ALLG CM13 ASCEND TRIAL | Authors: | Yeung, D.;Shanmuganathan, N.;Shortt, J.;Yong, A.;Chee, L.;Reynolds, J.;Viiala, N.;Cunningham, I.;Ross, D.;D'Souza, A.;Wright, M.;Harrup, R.;Forsyth, Cecily ;Filshie, R.;Lane, S.;Browett, P.;Grove, C.;Gazdar, S. G.;Walia, M.;Branford, S.;Grigg, A.;Hughes, T. | Affliation: | Central Coast Local Health District Gosford Hospital |
Issue Date: | 1-Jun-2026 | Department: | Haematology | Abstract: | HemaSphere 2026;10(Supplement 1):no pagination. | URI: | https://hdl.handle.net/1/3174 | Publicaton type: | Conference Abstract | Keywords: | Haematology Hematology |
| Appears in Collections: | Health Service Research |
Show full item record
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.